antibody landscapes influenza virus infection vaccination 
introduce antibody landscape method quantitative analysis antibody-mediated immunity antigenically variable pathogens achieved accounting antigenic variation among pathogen strains generated antibody landscapes study immune profiles covering years influenza a/h3n2 virus evolution individuals monitored infection years individuals pre postvaccination upon infection vaccination titers increased broadly including previously encountered viruses far beyond extent cross-reactivity observed primary infection explored implications vaccination found use antigenically advanced virus dual benefit inducing antibodies advanced previous antigenic clusters results indicate preemptive vaccine updates may improve influenza vaccine efficacy previously exposed individuals 
